Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KRAB-A domain-containing protein 2 (KRBA2) is a human protein that includes the KRAB domain, a strong transcriptional repression module usually found at the N-terminal region of certain transcription factors[2][1][3][6]. The KRAB domain functions by recruiting corepressor proteins, especially KAP1 (TRIM28), resulting in formation of heterochromatin and gene silencing[1][3][5]. Proteins in this family typically possess multiple C2H2 zinc finger motifs that allow sequence-specific DNA binding[1][2][5]. While the biological role of KRBA2 itself has not been established experimentally, the broader KRAB zinc finger protein family is associated with regulation of transcription during development, cell differentiation, proliferation, and apoptosis[1][5]. KRAB proteins are vertebrate-specific and represent the largest class of transcriptional regulators in mammals[5][6]. KRBA2 has not been linked to known disease roles or clinical drug interactions, and is not regarded as a therapeutic target at this time[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KRAB-A domain-containing protein 2 (KRBA2).